title: Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.
abstract: We have previously shown that human cancer cells deficient in DNA mismatch repair (MMR) are resistant to the chemotherapeutic methylating agent temozolomide (TMZ) and can be sensitized by the base excision repair (BER) blocking agent methoxyamine (MX) [21]. To further characterize BER-mediated repair responses to methylating agent-induced DNA damage, we have now evaluated the effect of MX on TMZ-induced DNA single strand breaks (SSB) by alkaline elution and DNA double strand breaks (DSB) by pulsed field gel electrophoresis in SW480 (O6-alkylguanine-DNA-alkyltransferase [AGT]+, MMR wild type) and HCT116 (AGT+, MMR deficient) colon cancer cells. SSB were evident in both cell lines after a 2-h exposure to equitoxic doses of temozolomide. MX significantly increased the number of TMZ-induced DNA-SSB in both cell lines. In contrast to SSB, TMZ-induced DNA-DSB were dependent on MMR status and were time-dependent. Levels of 50 kb double stranded DNA fragments in MMR proficient cells were increased after TMZ alone or in combination with O6-benzylguanine or MX, whereas, in MMR deficient HCT116 cells, only TMZ plus MX produced significant levels of DNA-DSB. Levels of AP endonuclease, XRCC1 and polymerase beta were present in both cell lines and were not significantly altered after MX and TMZ. However, cleavage of a 30-mer double strand substrate by SW480 and HCT116 crude cell extracts was inhibited by MX plus TMZ. Thus, MX potentiation of TMZ cytotoxicity may be explained by the persistence of apurinic/apyrimidinic (AP) sites not further processed due to the presence of MX. Furthermore, in MMR-deficient, TMZ-resistant HCT116 colon cancer cells, MX potentiates TMZ cytotoxicity through formation of large DS-DNA fragmentation and subsequent apoptotic signalling.
authors.affiliation: Division of Hematology-Oncology, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, OH 44106-4937, USA.
authors.forename: P
authors.initials: P
authors.lastname: Taverna
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.forename: H S
authors.initials: HS
authors.lastname: Hwang
authors.forename: A J
authors.initials: AJ
authors.lastname: Hanson
authors.forename: T J
authors.initials: TJ
authors.lastname: Kinsella
authors.forename: S L
authors.initials: SL
authors.lastname: Gerson
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D003110:Colonic Neoplasms / Q000235:genetics* / Q000473:pathology; D004249:DNA Damage; D004260:DNA Repair; D004273:DNA, Neoplasm / Q000187:drug effects*; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000494:pharmacology*; D004357:Drug Synergism; D016521:Electrophoresis, Gel, Pulsed-Field; D006801:Humans; D006898:Hydroxylamines / Q000494:pharmacology*; D020287:In Situ Nick-End Labeling; D000077204:Temozolomide; D014407:Tumor Cells, Cultured
chemical_list: D004273:DNA, Neoplasm; D006898:Hydroxylamines; D003606:Dacarbazine; C005214:methoxyamine; D000077204:Temozolomide